Form 8-K CASSAVA SCIENCES INC For: Jul 01
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/13/2026
- S&P 500 flat as chipmakers fall and bank earnings roll in
- Oil prices mixed as US-Russia diesel deal hopes offset Saudi Yemen attacks
- JPMorgan shares edge lower after third-quarter FICC revenue miss
- Fed’s Waller says US bond yield rise driven by growth, not inflation
- Wells Fargo beats profit estimates despite revenue miss
- Bausch + Lomb names Appio interim CEO as Saunders departs
- Cerebras Systems hits new 52-week low on unlock concerns
- CoreWeave stock drops on insider selling notice
- Getty Images to go private via prepackaged Chapter 11 restructuring
- Sysco calls on Teamsters to end LA strike after economic deal reached
Jones Trading Downgrades Cassava Sciences (SAVA) to Hold, 'Multiple Uncertainties'
July 1, 2024 9:43 AM EDTJones Trading analyst Soumit Roy downgraded Cassava Sciences (NASDAQ: SAVA) from Buy to Hold.
The analyst comments "Following the federal grand jury indictment of the former consultant of Cassava Sciences, Dr. Hoau-Yan Wang, last Friday (link), and today's 8-K (link) mentioning the... More
Cassava Sciences (SAVA) Provides Update on Government Investigations
July 1, 2024 8:09 AM EDTCassava Sciences (NASDAQ: SAVA) disclosed:
Item 8.01. Other Events.
Update on Government Investigations
Cassava Sciences, Inc. (Cassava or the Company) has been engaging with the U.S. Department of Justice (the DOJ) and the U.S. Securities and Exchange Commission (the SEC) in connection with ongoing investigations into the Company and two senior employees of the Company. Cassava is cooperating with the DOJ and SEC in connection with these investigations.
In the course of ongoing discussions with the SEC regarding the Companys Phase 2b study of simufilam in Alzheimers... More



